المؤلفون: Joglekar T; Department of Biological Sciences, University of Maryland, Baltimore County, Baltimore, MD., Chin A; Department of Biological Sciences, University of Maryland, Baltimore County, Baltimore, MD., Voskanian-Kordi A; Department of Biological Sciences, University of Maryland, Baltimore County, Baltimore, MD., Baek S; Department of Mathematics and Statistics, University of Maryland, Baltimore County, Baltimore, MD., Raja A; Department of Biological Sciences, University of Maryland, Baltimore County, Baltimore, MD., Rege A; Department of Biological Sciences, University of Maryland, Baltimore County, Baltimore, MD., Huang W; Department of Pharmaceutical Sciences, University of Maryland, Baltimore, Baltimore, MD., Kane M; Department of Pharmaceutical Sciences, University of Maryland, Baltimore, Baltimore, MD., Laiho M; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, MD., Webb TR; Wildflower Biopharma, Inc, San Diego, CA., Fan X; Department of Microbiology and Immunology, University of Maryland Baltimore School of Medicine, Baltimore, MD.; University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center, Baltimore, MD., Rubenstein M; Department of Biological Sciences, University of Maryland, Baltimore County, Baltimore, MD., Bieberich CJ; Department of Biological Sciences, University of Maryland, Baltimore County, Baltimore, MD.; Department of Microbiology and Immunology, University of Maryland Baltimore School of Medicine, Baltimore, MD., Li X; Department of Biological Sciences, University of Maryland, Baltimore County, Baltimore, MD.

المصدر: Blood advances [Blood Adv] 2024 Aug 13; Vol. 8 (15), pp. 3880-3892.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/metabolism , Leukemia, Myeloid, Acute*/pathology , Proto-Oncogene Proteins c-pim-1*/antagonists & inhibitors , Proto-Oncogene Proteins c-pim-1*/metabolism , Protein Kinase Inhibitors*/pharmacology , Protein Kinase Inhibitors*/therapeutic use, Humans ; Mice ; Animals ; Cell Line, Tumor ; Substrate Specificity ; RNA Splicing/drug effects ; Xenograft Model Antitumor Assays

المؤلفون: Zhou J; 940th Hospital of the Joint Logistics Support Force of the People's Liberation Army of China, Lanzhou, Gansu 730050, China. wutaozhen@yeah.net., Wu T, Liu W

المصدر: Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics [Zhonghua Yi Xue Yi Chuan Xue Za Zhi] 2024 Aug 10; Vol. 41 (8), pp. 1010-1015.

نوع المنشور: Journal Article; Review; English Abstract

بيانات الدورية: Publisher: Sichuan University Country of Publication: China NLM ID: 9425197 Publication Model: Print Cited Medium: Print ISSN: 1003-9406 (Print) Linking ISSN: 10039406 NLM ISO Abbreviation: Zhonghua Yi Xue Yi Chuan Xue Za Zhi Subsets: MEDLINE

مواضيع طبية MeSH: DNA Methyltransferase 3A* , DNA (Cytosine-5-)-Methyltransferases*/genetics , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/enzymology, Humans ; DNA Methylation ; Gene Expression Regulation, Leukemic

المؤلفون: Jiang L; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Zhao Y; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China.; Department of Hematology, The Third Affiliated Hospital of Southern Medical University, Guangzhou, China., Liu F; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Huang Y; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Zhang Y; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Yuan B; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Cheng J; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Yan P; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Ni J; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Jiang Y; School of Medicine, Zhengzhou University, Zhengzhou, China., Wu Q; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China., Jiang X; Department of Hematology, Nanfang Hospital, Southern Medical University, Guangzhou, China. jxj3331233@163.com.

المصدر: Cell communication and signaling : CCS [Cell Commun Signal] 2024 Aug 07; Vol. 22 (1), pp. 391. Date of Electronic Publication: 2024 Aug 07.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: BioMed Central Country of Publication: England NLM ID: 101170464 Publication Model: Electronic Cited Medium: Internet ISSN: 1478-811X (Electronic) Linking ISSN: 1478811X NLM ISO Abbreviation: Cell Commun Signal Subsets: MEDLINE

مواضيع طبية MeSH: fms-Like Tyrosine Kinase 3*/genetics , fms-Like Tyrosine Kinase 3*/metabolism , fms-Like Tyrosine Kinase 3*/antagonists & inhibitors , Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/pathology , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/metabolism , Glycogen Synthase Kinase 3 beta*/metabolism , Glycogen Synthase Kinase 3 beta*/genetics , beta Catenin*/metabolism , beta Catenin*/genetics , Phosphotransferases (Alcohol Group Acceptor)*/metabolism , Phosphotransferases (Alcohol Group Acceptor)*/genetics , Phosphotransferases (Alcohol Group Acceptor)*/antagonists & inhibitors , Protein Phosphatase 2*/metabolism , Protein Phosphatase 2*/genetics , Protein Phosphatase 2*/antagonists & inhibitors, Humans ; Animals ; Mice ; Cell Line, Tumor ; Sorafenib/pharmacology ; Apoptosis/drug effects ; Protein Kinase Inhibitors/pharmacology ; Signal Transduction/drug effects ; Cell Proliferation/drug effects ; Drug Synergism ; Xenograft Model Antitumor Assays ; Drug Resistance, Neoplasm/drug effects ; Drug Resistance, Neoplasm/genetics

المؤلفون: Sakthivel D; Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.; Texas Children's Hospital William T. Shearer Center for Human Immunobiology, Houston, TX 77030, USA.; Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, TX 77030, USA., Brown-Suedel AN; Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.; Texas Children's Hospital William T. Shearer Center for Human Immunobiology, Houston, TX 77030, USA., Lopez KE; Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.; Texas Children's Hospital William T. Shearer Center for Human Immunobiology, Houston, TX 77030, USA., Salgar S; Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.; Texas Children's Hospital William T. Shearer Center for Human Immunobiology, Houston, TX 77030, USA., Coutinho LE; Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.; Texas Children's Hospital William T. Shearer Center for Human Immunobiology, Houston, TX 77030, USA., Keane F; Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA., Huang S; Advanced Technology Cores, Department of Molecular and Cellular Biology, Huffington Department of Education, Innovation & Technology, Dan L. Duncan Cancer Center, Baylor College of Medicine, Houston, TX 77030, USA., Sherry KM; Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA., Charendoff CI; Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA., Dunne KP; Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA., Robichaux DJ; Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA., Vargas-Hernández A; Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.; Texas Children's Hospital William T. Shearer Center for Human Immunobiology, Houston, TX 77030, USA., Le B; Texas Children's Hospital William T. Shearer Center for Human Immunobiology, Houston, TX 77030, USA., Shin CS; Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, TX 77030, USA., Carisey AF; Department of Cell and Molecular Biology, St. Jude Children's Research Hospital, 262 Danny Thomas Place, Memphis, TN 38105, USA., Poreba M; Department of Chemical Biology and Bioimaging, Faculty of Chemistry, Wroclaw University of Science and Technology, Wroclaw 50370, Poland., Flanagan JM; Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.; Texas Children's Hospital William T. Shearer Center for Human Immunobiology, Houston, TX 77030, USA., Bouchier-Hayes L; Division of Hematology-Oncology, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.; Texas Children's Hospital William T. Shearer Center for Human Immunobiology, Houston, TX 77030, USA.; Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, TX 77030, USA.

المصدر: Science advances [Sci Adv] 2024 Aug 02; Vol. 10 (31), pp. eadj3145. Date of Electronic Publication: 2024 Aug 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Association for the Advancement of Science Country of Publication: United States NLM ID: 101653440 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2375-2548 (Electronic) Linking ISSN: 23752548 NLM ISO Abbreviation: Sci Adv Subsets: MEDLINE

مواضيع طبية MeSH: Nucleophosmin* , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/pathology , Leukemia, Myeloid, Acute*/metabolism , Nuclear Proteins*/metabolism , Nuclear Proteins*/genetics , Caspase 2*/metabolism , Caspase 2*/genetics , Cell Proliferation* , Mutation* , Apoptosis*, Humans ; Animals ; Cell Differentiation ; Cell Line, Tumor ; Cell Self Renewal/genetics ; Mice ; DNA Damage

المؤلفون: Qin Y; Department of Hematology, First Affiliated Hospital of Anhui Medical University, 218Jixi Road, Hefei, 230022, Anhui, China., Pu X; Department of Critical Care Medicine, First Affiliated Hospital of Anhui Medical University, 218Jixi Road, Hefei, 230022, Anhui, China., Hu D; Clinical Cancer Institute, Center for Translational Medicine, Naval Medical University, 800 Xiangyin Road, Shanghai, China., Yang M; Department of Hematology, First Affiliated Hospital of Anhui Medical University, 218Jixi Road, Hefei, 230022, Anhui, China. yangmz89@163.com.

المصدر: Scientific reports [Sci Rep] 2024 Aug 02; Vol. 14 (1), pp. 17874. Date of Electronic Publication: 2024 Aug 02.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101563288 Publication Model: Electronic Cited Medium: Internet ISSN: 2045-2322 (Electronic) Linking ISSN: 20452322 NLM ISO Abbreviation: Sci Rep Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/pathology , Machine Learning* , Biomarkers, Tumor*/genetics , Biomarkers, Tumor*/metabolism, Humans ; Prognosis ; Female ; Male ; Cell Death/drug effects ; Apoptosis/drug effects ; Middle Aged ; Transcriptome

المؤلفون: Cai Y; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang Province, 150001, China., Li D; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang Province, 150001, China., Lv D; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang Province, 150001, China., Yu J; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang Province, 150001, China., Ma Y; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang Province, 150001, China., Jiang T; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang Province, 150001, China., Ding N; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang Province, 150001, China., Liu Z; Affiliated Foshan Maternity & Child Healthcare Hospital, Southern Medical University, Guangzhou, China. whitexblack@163.com., Li Y; School of Interdisciplinary Medicine and Engineering, Harbin Medical University, Harbin, 150081, China. liyongsheng@ems.hrbmu.edu.cn., Xu J; College of Bioinformatics Science and Technology, Harbin Medical University, Harbin, Heilongjiang Province, 150001, China. xujuanbiocc@ems.hrbmu.edu.cn.

المصدر: Scientific data [Sci Data] 2024 Aug 01; Vol. 11 (1), pp. 831. Date of Electronic Publication: 2024 Aug 01.

نوع المنشور: Journal Article; Dataset

بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101640192 Publication Model: Electronic Cited Medium: Internet ISSN: 2052-4463 (Electronic) Linking ISSN: 20524463 NLM ISO Abbreviation: Sci Data Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/immunology , Leukemia, Myeloid, Acute*/therapy , Immunotherapy* , Antigens, Neoplasm*/immunology, Humans ; Histocompatibility Antigens Class I/immunology

المصدر: Blood [Blood] 2024 Aug 01; Vol. 144 (5), pp. 589.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: United States NLM ID: 7603509 Publication Model: Print Cited Medium: Internet ISSN: 1528-0020 (Electronic) Linking ISSN: 00064971 NLM ISO Abbreviation: Blood Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/blood , Leukemia, Myeloid, Acute*/diagnosis , Mutation*, Humans ; Prognosis

المؤلفون: Dodhiawala PB, Cichocki F

المصدر: The Journal of clinical investigation [J Clin Invest] 2024 Aug 01; Vol. 134 (15). Date of Electronic Publication: 2024 Aug 01.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: American Society for Clinical Investigation Country of Publication: United States NLM ID: 7802877 Publication Model: Electronic Cited Medium: Internet ISSN: 1558-8238 (Electronic) Linking ISSN: 00219738 NLM ISO Abbreviation: J Clin Invest Subsets: MEDLINE

مواضيع طبية MeSH: CD8 Antigens*/metabolism , CD8 Antigens*/immunology , CD8 Antigens*/genetics , Core Binding Factor Alpha 3 Subunit*/genetics , Core Binding Factor Alpha 3 Subunit*/metabolism , Core Binding Factor Alpha 3 Subunit*/immunology , Interleukin-15*/immunology , Interleukin-15*/metabolism , Interleukin-15*/genetics , Killer Cells, Natural*/immunology , Killer Cells, Natural*/metabolism , Leukemia, Myeloid, Acute*/immunology , Leukemia, Myeloid, Acute*/pathology , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/metabolism, Humans

المؤلفون: Lin L; Department of Hematology, The Affiliated Hospital of Chengde Medical College, Chengde, People's Republic of China., Xue S; Department of Bone Marrow Transplant, Beijing Lu Daopei Hospital, Beijing, People's Republic of China., Chen J; Division of Pathology & Laboratory Medicine, Hebei Yanda Lu Daopei Hospital, Langfang, People's Republic of China., Gu C; Department of Hematology, The Affiliated Hospital of Chengde Medical College, Chengde, People's Republic of China., Zhang J; Department of Hematology, The Affiliated Hospital of Chengde Medical College, Chengde, People's Republic of China., Xing E; Department of Central Laboratory, The Affiliated Hospital of Chengde Medical College, Chengde, People's Republic of China., Wang W; Department of Hematology, The Affiliated Hospital of Chengde Medical College, Chengde, People's Republic of China., Wang L; Department of Hematology, The Affiliated Hospital of Chengde Medical College, Chengde, People's Republic of China., Zhang Z; Department of Hematology, The Affiliated Hospital of Chengde Medical College, Chengde, People's Republic of China.

المصدر: Leukemia & lymphoma [Leuk Lymphoma] 2024 Aug; Vol. 65 (8), pp. 1181-1185. Date of Electronic Publication: 2024 Jul 23.

نوع المنشور: Letter; Case Reports; Journal Article

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: United States NLM ID: 9007422 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1029-2403 (Electronic) Linking ISSN: 10268022 NLM ISO Abbreviation: Leuk Lymphoma Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/drug therapy , Leukemia, Myeloid, Acute*/genetics , Leukemia, Myeloid, Acute*/diagnosis , Leukemia, Myeloid, Acute*/pathology , Antineoplastic Combined Chemotherapy Protocols*/therapeutic use , Antineoplastic Combined Chemotherapy Protocols*/adverse effects , Piperazines*/administration & dosage , Piperazines*/therapeutic use , Phthalazines*/administration & dosage , Phthalazines*/therapeutic use , RUNX1 Translocation Partner 1 Protein*/genetics, Humans ; Aged ; Core Binding Factor Alpha 2 Subunit/genetics ; Oncogene Proteins, Fusion/genetics ; Treatment Outcome ; Male ; Female ; Recurrence ; Neoplasm Recurrence, Local/drug therapy ; Neoplasm Recurrence, Local/pathology

المؤلفون: Alati C; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Pitea M; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Mico MC; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Marafioti V; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Greve B; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Pratico G; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Loteta B; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Cogliandro F; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Porto G; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Policastro G; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Utano G; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Sgarlata A; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Imbalzano L; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Delfino IM; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Montechiarello E; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Germano J; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy., Filippelli G; Oncology Department, Hospital of Paola (Cosenza), Cosenza, Italy., Martino M; Department of Hemato-Oncology and Radiotherapy, Grande Ospedale Metropolitano 'Bianchi-Melacrino-Morelli', Hematology and Stem Cell Transplantation and Cellular Therapies Unit (CTMO), Reggio Calabria, Italy.; Stem Cell Transplant Program CIC587, Reggio Calabria, Italy.

المصدر: Expert review of hematology [Expert Rev Hematol] 2024 Aug; Vol. 17 (8), pp. 515-525. Date of Electronic Publication: 2024 Jul 21.

نوع المنشور: Journal Article; Review

بيانات الدورية: Publisher: Taylor & Francis Country of Publication: England NLM ID: 101485942 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1747-4094 (Electronic) Linking ISSN: 17474094 NLM ISO Abbreviation: Expert Rev Hematol Subsets: MEDLINE

مواضيع طبية MeSH: Leukemia, Myeloid, Acute*/therapy , Leukemia, Myeloid, Acute*/drug therapy , Maintenance Chemotherapy*, Humans ; fms-Like Tyrosine Kinase 3/antagonists & inhibitors ; fms-Like Tyrosine Kinase 3/metabolism ; Hematopoietic Stem Cell Transplantation ; Staurosporine/analogs & derivatives ; Staurosporine/therapeutic use ; Protein Kinase Inhibitors/therapeutic use ; Antineoplastic Agents/therapeutic use ; Sorafenib/therapeutic use ; Phenylurea Compounds/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/therapeutic use ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Aniline Compounds ; Pyrazines ; Benzothiazoles